SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS

被引：0
|
作者：
Marques Vidas, Maria [1 ]
Domenech, Ester [1 ]
Martin Testillano, Lucia [1 ]
Maroto, Alba [1 ]
Lopez, Paula [1 ]
Portoles, Jose' M. [1 ]
机构：
[1] Puerta de Hierro Univ Hosp, Dept Nephrol, Majadahonda, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO167
引用
收藏
页码：I104 / I104
页数：1
相关论文
共 50 条
  • [21] Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group
    Clegg, Lindsay
    Heerspink, Hiddo L.
    Penland, Robert C.
    Tang, Weifeng
    Boulton, David W.
    Bachina, Srinivas
    Fox, Robert D.
    Fenici, Peter
    Thuresson, Marcus
    Mentz, Robert J.
    Hernandez, Adrian F.
    Bethel, M. Angelyn
    Holman, Rury R.
    DIABETES, 2018, 67
  • [22] SGLT2i and postglomerular vasodilation
    Jose Soler, Maria
    Porrini, Esteban
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    KIDNEY INTERNATIONAL, 2020, 97 (04) : 805 - 806
  • [23] Personal Hygiene and SGLT2i
    Raha, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [24] Stratifying the effects of SGLT2i
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (06) : 322 - 322
  • [25] Renal perfusion and SGLT2i
    Nielsen, Steffen Flindt
    Duus, Camilla
    Buus, Niels Henrik
    Bech, Jesper Noergaard
    Mose, Frank
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I350 - I352
  • [26] Stratifying the effects of SGLT2i
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2019, 16 : 322 - 322
  • [27] SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice
    Berger, Justin H.
    Matsuura, Timothy R.
    Bowman, Caitlyn E.
    Taing, Renee
    Patel, Jiten
    Lai, Ling
    Leone, Teresa C.
    Reagan, Jeffrey D.
    Haldar, Saptarsi M.
    Arany, Zoltan
    Kelly, Daniel P.
    CIRCULATION RESEARCH, 2024, 135 (05) : 632 - 634
  • [28] Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?
    de la Flor, Jose C.
    Villa, Daniel
    Cruzado, Leonidas
    Apaza, Jacqueline
    Valga, Francisco
    Zamora, Rocio
    Marschall, Alexander
    Cieza, Michael
    Deira, Javier
    Rodeles, Miguel
    BIOMEDICINES, 2023, 11 (07)
  • [29] Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors
    Qiu, Mei
    Ding, Liang-Liang
    Zhang, Miao
    Zhou, Hai-Rong
    DIABETES & VASCULAR DISEASE RESEARCH, 2021, 18 (02):
  • [30] SGLT2 inhibitors in people with and without T2DM
    Khunti, Kamlesh
    NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (02) : 75 - 76
12345